Cardiac Dimensions nabs $15.2 mln
Cardiac Dimensions, a developer of minimally invasive treatments that address heart failure and related cardiovascular conditions, has raised $15.2 million in funding. The investors included Life Sciences Partners, Aperture Venture Partners, Lumira Capital, M.H. Carnegie & Co. and Arboretum Ventures.
11 March 2015•3 mins read
